Articles tagged with Analgesics
New research adds to evidence that acetaminophen may prevent colon cancer in lab animals. The study found that pretreating animals with acetaminophen significantly protected them against cellular changes indicative of colon cancer. However, more animal research is needed before humans can be studied in clinical trials.
The balancing act between COX-1 and COX-2 enzymes plays a crucial role in protecting the heart from cardiovascular disease. The study found that PGI2 production is stimulated as a response to platelet interactions with the vessel wall, limiting the harmful effects of thromboxane.
A study of 93 patients hospitalised due to acetaminophen overdose found that those who accidentally overdosed fared less well, despite lower drug levels. Delayed treatment and alcohol consumption exacerbated liver damage and death risk.
A recent study by Ohio State University found that the DentiPatch, a small adhesive patch containing lidocaine, delivers longer and deeper relief from dental pain. The patch's anesthetic effects last up to 45 minutes, whereas traditional gel-based treatments only last about a minute.
A recent study found that migraine prevalence in the US has remained stable over the past decade, with many sufferers relying on over-the-counter medications. The study suggests that millions of people could benefit from proper medical attention, which can lead to more effective treatment and improved quality of life.
A USGS survey found 82 organic wastewater contaminants in at least one stream across the US, including medications, caffeine and antimicrobial soaps. The presence of mixtures was a surprising finding, with some streams containing up to 38 chemicals.
A Michigan Medicine-led study has successfully improved the odds that patients receive life-saving treatments after a heart attack. The study, GAP (Guidelines Applied in Practice), used reminders, checklists, and educational materials to boost adherence to American College of Cardiology guidelines. As a result, hospitals saw significan...
A recent study published in the Mayo Clinic Proceedings found that daily NSAID use reduced prostate cancer risk by up to 60% in men aged 60 and older. The study, which followed 1,362 Caucasian men for an average of five and a half years, suggests that the beneficial effect may increase with age.
The Center for the Study of Pharmacologic Plasticity in the Presence of Pain at Wake Forest will study changes in the spinal cord caused by certain medicines and their impact on pain sensation. The research aims to develop new, effective pain treatments for patients with nerve injury or neuropathic pain.
Breakthrough pain in cancer patients incurs $12,000/year in medical services; non-breakthrough patients incur $2,400/year. Study finds link between breakthrough pain and increased need for hospitalizations, emergency room visits, and doctor visits.
UCSF scientists have demonstrated in animals how morphine's potent painkilling powers can be sustained without increasing dosages. By pairing morphine with an opioid that facilitates endocytosis, they showed that the natural cellular process can arrest the pattern of tolerance to morphine.
The USPSTF recommends discussing aspirin therapy with adult patients at increased risk of coronary heart disease, such as those with unfavorable cholesterol levels, smoking, or hypertension. Aspirin may help prevent heart attacks in these individuals, but its benefits and harms should be carefully weighed.
Researchers found that regular use of aspirin cuts coronary heart disease risk by 28% in people at heightened risk. Doctors should discuss pros and cons with patients to determine individualized decision, considering age, habits, and medical histories.
A new study strengthens evidence that aspirin prevents heart attacks and strokes in patients with high-risk conditions like angina and diabetes. Researchers estimate an extra 40,000 lives could be saved annually if more people with these conditions receive aspirin.
A genetic mechanism involved in pain modulation has been discovered, which could lead to an entirely new approach to pain control. Genetically engineered mice lacking the DREAM gene showed dramatic loss of pain sensitivity compared to those with the gene.
Six popular herbal therapies - Ginkgo, St John's wort, Ginseng, Echinacea, Saw palmetto, and Kava - have varying levels of effectiveness and safety. Prednisone, a glucocorticoid, reduced swelling and progression of damage to joints in patients with early active rheumatoid arthritis.
Researchers found that taking ibuprofen daily can reduce the effectiveness of low-dose aspirin in preventing heart attacks. This interaction occurs because ibuprofen blocks aspirin from binding to the COX-1 enzyme, which is essential for platelet clotting and heart protection.
Researchers found that brain structures associated with rewarding experiences are also activated by painful stimuli, leading to a better understanding of pain's emotional component. This study may lead to the development of new approaches to diagnosing and treating chronic pain.
A study by UCSF found that cancer patients often prefer to experience pain over the side effects of opioid analgesics. Effective pain management requires repeated assessment and adjustments in dosage, according to experts.
A new UCSF study found that many cancer patients are not taking around-the-clock and as-needed pain medicines as prescribed by their physicians. This results in inadequate pain relief, with only 29.2% of patients receiving both long-acting and short-acting opioids.
A recent study published in the New England Journal of Medicine found that warfarin and aspirin provide no significant difference in preventing another stroke in ischemic stroke patients without atrial fibrillation. The study, which followed 2,206 individuals for two years, showed no statistically significant differences between the tw...
A 7-year clinical trial comparing aspirin and warfarin found that both drugs are safe and effective in preventing recurrent strokes in most patients. Aspirin slows clotting of blood platelets, while warfarin inhibits circulating clotting proteins.
A new study by Johns Hopkins Medicine suggests that nitroglycerin relief does not accurately predict coronary artery disease, challenging the long-held assumption. The study found that only 28% of patients with heart disease experienced chest pain relief from nitroglycerin.
Researchers find that heparin and compression stockings can effectively prevent deep-vein thrombosis (DVT) in people at high risk for clots, particularly those with a history of heart disease or stroke. Compression stockings were found to significantly reduce DVT incidence by 18.75 times compared to controls.
A recent study published by the American Academy of Neurology found bupropion SR to be clinically effective for treating neuropathic pain. Approximately three-quarters of patients experienced a 30% reduction in pain symptoms with bupropion SR, while those on placebo saw little improvement.
Researchers found that aspirin is not cost-effective addition to national strategy for reducing death from colorectal cancer. Screening methods, such as flexible sigmoidoscopy and yearly fecal occult blood testing, remain highly effective and cost-efficient options.
Researchers found that aspirin does not reduce costs and increase life expectancy for colorectal cancer prevention. Regular screening tests remain highly effective and cost-effective, even for patients taking aspirin for other reasons.
Researchers found that morphine significantly relieved both types of pain, while lidocaine only relieved stump pain. The study suggests different therapeutic sensitivities and mechanisms for stump and phantom pain. Morphine's action on both peripheral and central nervous systems may provide new treatment options.
A clinical trial found acupuncture to be as effective as the commonly used medication ondansetron in reducing postoperative nausea and vomiting. Additionally, women who received acupuncture reported lower levels of moderate to severe pain after breast surgery, a surprising discovery that opens up new possibilities for pain management.
Researchers at Saint Louis University School of Medicine found that small doses of botulinum toxin Type A effectively relaxed muscles involved in triggering tension headaches, resulting in reduced frequency and intensity for most patients. The injections were also easier to control symptoms.
A UCSF study found that patients with substance abuse-related medical conditions benefit from integrated medical and addiction treatment, leading to improved abstinence rates and reduced inpatient use. The two-year study showed no significant differences in total abstinence rates between the integrated and independent care groups.
Researchers discovered a new drug that can restore bowel function without affecting pain relief, enabling patients to recover faster and be discharged sooner. The study found significant improvements in recovery times for patients taking the 6mg dose of ADL 8-2698.
A double-blind, placebo-controlled study found that patients with diabetic neuropathy experienced significant pain reduction with Lamictal treatment. Almost half of the patients achieved a 50% reduction in pain, and most were able to reduce their need for additional pain medication.
Murray Goodman, a bioorganic chemist at the University of California, San Diego, has developed new strategies to create more effective and selective drugs. His research aims to mimic the action of peptides, which help direct processes in the body, and improve upon their natural opioids.
Victor Snieckus has invented more efficient methods for creating organometallic compounds, which have applications in pharmaceuticals, agriculture, and electronics. His research has led to the development of a new painkiller, fungicides for wheat crops, and conducting materials.
Studies reveal a connection between neuronal plasticity and chronic neuropathic pain. Gene therapy targeting protein kinase C shows promise in reducing sensitivity to pain. Such findings may lead to innovative treatments for persistent and debilitating pain conditions.
Dr. Barr will investigate the relationship between rising acetaminophen use and a 20-year increase in asthma prevalence, exploring potential mechanisms behind the association. The research aims to inform treatment strategies and public education about pain medication use.
A unique experiment studying chemical activity in human brains while experiencing sustained pain revealed long-suspected connections between pain-dampening changes in brain chemistry and sensory/emotional responses. The findings may help researchers better understand prolonged pain and find more effective ways to relieve it.
A study in Calicut, India found no instances of misuse or diversion of oral morphine over 2 years. The research shows that opioids can be dispensed safely for home use with proper controls in place, overcoming regulatory barriers.
A study by Stock et al. reveals that genetic disruption of the PGE2 receptor EP1 significantly reduces pain behavior and blood pressure responses to inflammation. The findings suggest that NSAID treatment's analgesic effect can be explained by inhibition of signaling through this single receptor type.
A new drug, lamotrigine, has been shown to reduce central post-stroke pain in patients by an average of 30 percent. The treatment was found to be effective for patients who could not tolerate amitriptyline due to its side effects.
A long duration of regular aspirin use is associated with a significant increase in pancreatic cancer risk among women. Women taking 14 or more tablets per week experience nearly an 86% increased risk, while those taking six to 13 tablets per week see a 41% higher risk.
A new study establishes a link between gastroesophageal reflux and allergies, including environmental allergens like pollens and molds. The discovery could lead to new treatments for children with eosinophilic esophagitis and adults with refractory reflux.
A recent study by OHSU researchers found that 96% of physicians and nurses believe increased family expectations for pain management contributed to the observed increase in family reports of pain among dying patients. Additionally, decreased physician prescribing of pain medications (66%) and reduced nurse administration of pain medica...
A new clinical trial will compare the effectiveness of aspirin, clopidogrel, and warfarin in preventing heart attacks, strokes, and deaths in patients with chronic heart failure. The study, funded by the VA, will enroll 4,500 patients and provide insights into which medication is most effective, safe, and cost-efficient.
A Yale study of over 51,000 participants found that taking aspirin daily reduces the risk of a first heart attack by 32%. However, it did not significantly reduce overall stroke or cardiovascular death rates, and may increase the risk of hemorrhagic stroke.
A study published in the Lancet found that a catheter laser procedure combined with medication is more effective than medication alone in treating severe chest pain. The procedure, known as PTMR, stimulates new blood vessel growth and increases circulation to relieve angina symptoms.
A survey conducted by Dr. Maria Silveira found that many patients and families in Oregon are unaware of their basic rights regarding end-of-life care. The results suggest a need for healthcare providers to actively educate patients about their options, including refusal of treatment, withdrawal of care, assisted suicide, and euthanasia.
A University of Maryland study found that high cholesterol hinders the effectiveness of aspirin in reducing platelet aggregation and preventing heart attacks. The study showed that 60% of patients with high cholesterol levels above 220mg/dL remained at increased risk despite taking daily aspirin doses.
Researchers at UCLA and Cambridge report a breakthrough in pain medicine that delivers painkillers directly to affected areas, eliminating unwanted side effects. A single injection of the new medication can alleviate pain for several days, offering a significant improvement over current treatments.
A University of Pennsylvania study suggests that taking ibuprofen before aspirin can inhibit the cardioprotective benefits gained from a daily aspirin regimen. The study found no competitive interaction between aspirin and Tylenol or Vioxx when taken separately.
Researchers found that 6-beta naltrexol, a metabolite of naltrexone, can reduce alcohol drinking in rats. The study suggests that 6-beta naltrexol is a potential new medication for treating alcohol dependence.
A comprehensive program involving exercise, weight loss, and joint protection principles is necessary for effective osteoarthritis management. Over-the-counter acetaminophen may be the only required medication for mild-to-moderate pain relief.
A study published in JAMA found that patients taking Celebrex had two- to threefold fewer serious gastrointestinal complications compared to those receiving ibuprofen or diclofenac. The medication was also associated with lower incidence of stomach upset, abdominal pain, and nausea.
The European Respiratory Society warns that hundreds of medicines can cause lung diseases, with 310 therapeutic substances identified as having iatrogenic effects. Early withdrawal of these medicines can reduce the risk of damaging sequelae in 70% of cases.
Researchers present innovative solutions for weight management, metal protection, and pharmaceutical advancements. A dietary supplement may help control weight, fat, and diabetes, while a new coating extends the life of metals tenfold. Additionally, a gentler form of aspirin is developed using polymers.
A potentially safer, more potent form of aspirin made from polymers called PolyAspirin could eliminate stomach irritation and other side effects. The polymer-based drug consists of linked aspirin molecules that break down in the intestine, allowing for efficient delivery and reduced side effects.
Researchers found that ibuprofen significantly reduced inflammation and amyloid plaques in an animal model of Alzheimer's disease, which may help prevent the disease. The study suggests that taking anti-inflammatory drugs early on could delay the onset of AD by about a decade.
Researchers found that administering low to moderate doses of kappa-opioids in conjunction with naloxone causes profound, prolonged pain relief in both men and women. This discovery provides a significant alternative to morphine with minimal side effects.
A large randomized clinical trial shows that self-hypnotic relaxation techniques can decrease pain medication use, reduce operating room time, and improve vital signs during surgery. The study's findings suggest that hypnosis can be a safe and effective method for reducing anxiety and pain in patients undergoing invasive procedures.